Some evidence suggests dual agonists may help reduce nausea in certain patients
If you have epilepsy and are considering Wegovy for weight management, involve both your prescriber and your neurologist in the decision
Some people experience reduced effectiveness over time , but this is related to metabolic adaptation and dose adequacy, not injection timing
Therefore, they are nowadays recommended as first line therapy in patients with T2DM and atherosclerotic cardiovascular disease to reduce events, regardless of baseline or target HbA1c and concomitant glucose-lowering medication according to the 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes [31]
Pain scores improved by approximately 76% on the WOMAC scale, and more than 12% of Retatrutide-treated participants reported complete freedom from knee pain at week 68, compared to 4.2% on placebo
The benefits and risks of reaching the maximum dose are covered in more detail at the highest recommended semaglutide dose, which can guide people in making safe and informed decisions about their treatment